The risk of tendon xanthomas in familial hypercholesterolaemia is influenced by variation in genes of the reverse cholesterol transport pathway and the low-density lipoprotein oxidation pathway

European Heart Journal

Volumn 31, Issue 8, 2010, Pages 1007-1012

  Oosterveer, Daniëlla M ^a   Versmissen, Jorie ^a   Yazdanpanah, Mojgan ^a   Defesche, Joep C ^b   Kastelein, John J P ^b   Sijbrands, Eric J G ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Atherosclerosis; Familial hypercholesterolaemia; LDL oxidation; Reverse cholesterol transport; Xanthomas

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN A1; CHOLESTEROL ESTER TRANSFER PROTEIN; DNA; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ALLELE; ARTICLE; ATHEROSCLEROSIS; BLOOD SAMPLING; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; DNA EXTRACTION; FAMILIAL DISEASE; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HUMAN; HYPERCHOLESTEROLEMIA; HYPOTHESIS; LIPID OXIDATION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVERSE CHOLESTEROL TRANSPORT; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; TENDON; TRIACYLGLYCEROL BLOOD LEVEL; XANTHOMA;

ADULT; CHOLESTEROL; FEMALE; GENOTYPE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; LIPOPROTEINS, LDL; MALE; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; OXIDATION-REDUCTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; TENDINOPATHY; XANTHOMATOSIS;

EID: 77951133898     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehp538     Document Type: Article

References (52)

1. Oosterveer DM, Versmissen J, Yazdanpanah M, Hamza TH, Sijbrands EJ. Differ-ences in characteristics and risk of cardiovascular disease in familial hypercholes-terolemia patients with and without tendon xanthomas: a systematic review and meta-analysis. Atherosclerosis 2009;207:311-317.
2. Ohashi R, Mu H, Wang X, Yao Q, Chen C. Reverse cholesterol transport and cholesterol efflux in atherosclerosis. QJM 2005;98:845-856. (Pubitemid 43071450)
3. Lai CQ, Parnell LD, Ordovas JM. The APOA1/C3/A4/A5 gene cluster, lipid metabolism and cardiovascular disease risk. Curr Opin Lipidol 2005;16:153-166.
4. Kiss RS, Kavaslar N, Okuhira K, Freeman MW, Walter S, Milne RW, McPherson R, Marcel YL. Genetic etiology of isolated low HDL syndrome: incidence and het-erogeneity of efflux defects. Arterioscler Thromb Vasc Biol 2007;27:1139-1145. (Pubitemid 46646651)
5. Garasto S, Rose G, Derango F, Berardelli M, Corsonello A, Feraco E, Mari V, Maletta R, Bruni A, Franceschi C, Carotenuto L, De Benedictis G. The study of APOA1, APOC3 and APOA4 variability in healthy ageing people reveals another paradox in the oldest old subjects. Ann Hum Genet 2003;67:54-62. (Pubitemid 38312850)
6. Frikke-Schmidt R, Nordestgaard BG, Jensen GB, Steffensen R, Tybjaerg-Hansen A. Genetic variation in ABCA1 predicts ischemic heart disease in the general popu-lation. Arterioscler Thromb Vasc Biol 2008;28:180-186.
7. Drenos F, Whittaker JC, Humphries SE. The use of meta-analysis risk estimates for candidate genes in combination to predict coronary heart disease risk. Ann Hum Genet 2007;71:611-619. (Pubitemid 47087069)
8. Casas JP, Cavalleri GL, Bautista LE, Smeeth L, Humphries SE, Hingorani AD. Endo-thelial nitric-oxide synthase gene polymorphisms and cardiovascular disease: a HuGE review. Am J Epidemiol 2006;164:921-935. (Pubitemid 44729832)
9. Wong WM, Gerry AB, Putt W, Roberts JL, Weinberg RB, Humphries SE, Leake DS, Talmud PJ. Common variants of apolipoprotein A-IV differ in their ability to inhibit low-density lipoprotein oxidation. Atherosclerosis 2007;192: 266-274. (Pubitemid 46726327)
10. Yazdanpanah M, Aulchenko YS, Hofman A, Janssen JA, Sayed-Tabatabaei FA, van Schaik RH, Klungel OH, Stricker BH, Pols HA, Witteman JC, Lamberts SW, Oostra BA, van Duijn CM. Effects of the renin-angiotensin system genes and salt-sensitivity genes on blood pressure and atherosclerosis in the total population and patients with type 2 diabetes. Diabetes 2007;56:1905-1912.
11. Rode S, Rubic T, Lorenz RL. Alpha-tocopherol disturbs macrophage LXRalpha regulation of ABCA1/G1 and cholesterol handling. Biochem Biophys Res Commun 2008;369:868-872.
12. Pirillo A, Uboldi P, Pappalardo G, Kuhn H, Catapano AL. Modification of HDL3 by mild oxidative stress increases ATP-binding cassette transporter 1-mediated cholesterol efflux. Cardiovasc Res 2007;75:566-574. (Pubitemid 47080967)
13. Klerkx AH, El Harchaoui K, van der Steeg WA, Boekholdt SM, Stroes ES, Kastelein JJ, Kuivenhoven JA. Cholesteryl-ester transfer protein (CETP) inhibition beyond raising high-density lipoprotein cholesterol levels: pathways by which modulation of CETP activity may alter atherogenesis. Arterioscler Thromb Vasc Biol 2006;26:706-715. (Pubitemid 43732142)
14. Jansen AC, van Aalst-Cohen ES, Tanck MW, Trip MD, Lansberg PJ, Liem AH, van Lennep HW, Sijbrands EJ, Kastelein JJ. The contribution of classical risk factors to cardiovascular disease in familial hypercholesterolaemia: data in 2400 patients. J Intern Med 2004;256:482-490.
15. Jansen AC, van Aalst-Cohen ES, Hutten BA, Buller HR, Kastelein JJ, Prins MH. Guidelines were developed for data collection from medical records for use in retrospective analyses. J Clin Epidemiol 2005;58:269-274.
16. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracen-trifuge. Clin Chem 1972;18:499-502.
17. Koivisto PV, Koivisto UM, Miettinen TA, Kontula K. Diagnosis of heterozygous familial hypercholesterolemia. DNA analysis complements clinical examination and analysis of serum lipid levels. Arterioscler Thromb 1992;12:584-592.
18. Cheng S, Grow MA, Pallaud C, Klitz W, Erlich HA, Visvikis S, Chen JJ, Pullinger CR, Malloy MJ, Siest G, Kane JP. A multilocus genotyping assay for can-didate markers of cardiovascular disease risk. Genome Res 1999;9:936-949. (Pubitemid 29525202)
19. Zwarts KY, Clee SM, Zwinderman AH, Engert JC, Singaraja R, Loubser O, James E, Roomp K, Hudson TJ, Jukema JW, Kastelein JJ, Hayden MR. ABCA1 regu-latory variants influence coronary artery disease independent of effects on plasma lipid levels. Clin Genet 2002;61:115-125. (Pubitemid 36372616)
20. Jeenah M, Kessling A, Miller N, Humphries S. G to A substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipo-protein AI and high density lipoprotein cholesterol concentrations. Mol Biol Med 1990;7:233-241. (Pubitemid 20283936)
21. Reguero JR, Cubero GI, Batalla A, Alvarez V, Hevia S, Cortina A, Coto E. Apoli-poprotein A1 gene polymorphisms and risk of early coronary disease. Cardiology 1998;90:231-235. (Pubitemid 29039148)
22. Boekholdt SM, Sacks FM, Jukema JW, Shepherd J, Freeman DJ, McMahon AD, Cambien F, Nicaud V, de Grooth GJ, Talmud PJ, Humphries SE, Miller GJ, Eiriksdottir G, Gudnason V, Kauma H, Kakko S, Savolainen MJ, Arca M, Montali A, Liu S, Lanz HJ, Zwinderman AH, Kuivenhoven JA, Kastelein JJ. Cholesteryl-ester transfer protein TaqIB variant, high-density lipoprotein choles-terol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects. Circulation 2005;111:278-287.
23. Gudnason V, Kakko S, Nicaud V, Savolainen MJ, Kesaniemi YA, Tahvanainen E, Humphries S. Cholesteryl-ester transfer protein gene effect on CETP activity and plasma high-density lipoprotein in European populations. The EARS Group. Eur J Clin Invest 1999;29:116-128. (Pubitemid 29090250)
24. Corbex M, Poirier O, Fumeron F, Betoulle D, Evans A, Ruidavets JB, Arveiler D, Luc G, Tiret L, Cambien F. Extensive association analysis between the CETP gene and coronary heart disease phenotypes reveals several putative functional poly-morphisms and gene-environment interaction. Genet Epidemiol 2000;19:64-80. (Pubitemid 30445638)
25. Ahn YI, Kamboh MI, Aston CE, Ferrell RE, Hamman RF. Role of common genetic polymorphisms in the LDL receptor gene in affecting plasma cholesterol levels in the general population. Arterioscler Thromb 1994;14:663-670.
26. Hoppe C, Klitz W, Cheng S, Apple R, Steiner L, Robles L, Girard T, Vichinsky E, Styles L. Gene interactions and stroke risk in children with sickle-cell anemia. Blood 2004;103:2391-2396.
27. Humphries SE, Cooper JA, Talmud PJ, Miller GJ. Candidate gene genotypes, along with conventional risk factor assessment, improve estimation of coronary heart disease risk in healthy UK men. Clin Chem 2007;53:8-16.
28. Roest M, Rodenburg J, Wiegman A, Kastelein JJ, Voorbij HA. Paraoxonase geno-type and carotid intima-media thickness in children with familial hypercholester-olemia. Eur J Cardiovasc Prev Rehabil 2006;13:464-466.
29. Mackness B, Mackness MI, Arrol S, Turkie W, Durrington PN. Effect of the molecular polymorphisms of human paraoxonase (PON1) on the rate of hydrolysis of paraoxon. Br J Pharmacol 1997;122:265-268.
30. Leviev I, Deakin S, James RW. Decreased stability of the M54 isoform of paraox-onase as a contributory factor to variations in human serum paraoxonase concen-trations. J Lipid Res 2001;42:528-535.
31. Garin MC, James RW, Dussoix P, Blanche H, Passa P, Froguel P, Ruiz J. Paraoxo-nase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes. J Clin Invest 1997;99:62-66.
32. Kozich V, Janosik M, Sokolova J, Oliveriusova J, Orendac M, Kraus JP, Elleder D. Analysis of CBS alleles in Czech and Slovak patients with homocystinuria: report on three novel mutations E176K, W409X and 1223\+ 37 del99. J Inherited Metab Dis 1997;20:363-366.
33. Seo DM, Goldschmidt-Clermont PJ. Unraveling the genetics of atherosclerosis: implications for diagnosis and treatment. Expert Rev Mol Diagn 2007;7:45-51.
34. Tsai MY, Welge BG, Hanson NQ, Bignell MK, Vessey J, Schwichtenberg K, Yang F, Bullemer FE, Rasmussen R, Graham KJ. Genetic causes of mild hyperhomocystei-nemia in patients with premature occlusive coronary artery diseases. Atherosclero-sis 1999;143:163-170.
35. Carlquist JF, Muhlestein JB, Horne BD, Hart NI, Bair TL, Molhuizen HO, Anderson JL. The cholesteryl-ester transfer protein Taq1B gene polymorphism predicts clinical benefit of statin therapy in patients with significant coronary artery disease. Am Heart J 2003;146:1007-1014.
36. Mohrschladt MF, van der Sman-de Beer F, Hofman MK, van der Krabben M, Westendorp RG, Smelt AH. TaqIB polymorphism in CETP gene: the influence on incidence of cardiovascular disease in statin-treated patients with familial hypercholesterolemia. Eur J Hum Genet 2005;13:877-882.
37. Tobin MD, Braund PS, Burton PR, Thompson JR, Steeds R, Channer K, Cheng S, Lindpaintner K, Samani NJ. Genotypes and haplotypes predisposing to myocardial infarction: a multilocus case-control study. Eur Heart J 2004;25:459-467.
38. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
39. Tall AR, Small DM, Lees RS. Interaction of collagen with the lipids of tendon xanthomata. J Clin Invest 1978;62:836-846.
40. Watanabe Y, Ito T, Shiomi M, Tsujita Y, Kuroda M, Arai M, Fukami M, Tamura A. Preventive effect of pravastatin sodium, a potent inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on coronary atherosclerosis and xanthoma in WHHL rabbits. Biochimica Biophys Acta 1988;960:294-302.
41. Yamamoto A, Hara H, Takaichi S, Wakasugi J, Tomikawa M. Effect of probucol on macrophages, leading to regression of xanthomas and atheromatous vascular lesions. Am J Cardiol 1988;62:31B-36B.
42. Aji W, Ravalli S, Szabolcs M, Jiang XC, Sciacca RR, Michler RE, Cannon PJ. L-arginine prevents xanthoma development and inhibits atherosclerosis in LDL receptor knockout mice. Circulation 1997;95:430-437.
43. Oosterveer DM, Versmissen J, Yazdanpanah M, van der Net JB, Defesche JC, Kastelein JJ, Sijbrands EJ. 5-Lipoxygenase activating protein (ALOX5AP) gene var-iants associate with the presence of xanthomas in familial hypercholesterolemia. Atherosclerosis 2009;206:223-227.
44. Wong WM, Hawe E, Li LK, Miller GJ, Nicaud V, Pennacchio LA, Humphries SE, Talmud PJ. Apolipoprotein AIV gene variant S347 is associated with increased risk of coronary heart disease and lower plasma apolipoprotein AIV levels. Circ Res 2003;92:969-975.
45. Lin X, Song K, Lim N, Yuan X, Johnson T, Abderrahmani A, Vollenweider P, Stirnadel H, Sundseth SS, Lai E, Burns DK, Middleton LT, Roses AD, Matthews PM, Waeber G, Cardon L, Waterworth DM, Mooser V. Risk prediction of prevalent diabetes in a Swiss population using a weighted genetic score\the CoLaus Study. Diabetologia 2009;52:600-608.
46. Yamamoto A, Matsuzawa Y, Yokoyama S, Funahashi T, Yamamura T, Kishino B. Effects of probucol on xanthomata regression in familial hypercholesterolemia. Am J Cardiol 1986;57:29H-35H.
47. Calabresi L, Favari E, Moleri E, Adorni MP, Pedrelli M, Costa S, Jessup W, Gelissen IC, Kovanen PT, Bernini F, Franceschini G. Functional LCAT is not required for macrophage cholesterol efflux to human serum. Atherosclerosis 2009;204:141-146.
48. Roberts CG, Shen H, Mitchell BD, Damcott CM, Shuldiner AR, Rodriguez A. Var-iants in scavenger receptor class B type I gene are associated with HDL choles-terol levels in younger women. Human Hered 2007;64:107-113.
49. Rodriguez-Esparragon F, Rodriguez-Perez JC, Hernandez-Trujillo Y, Macias-Reyes A, Medina A, Caballero A, Ferrario CM. Allelic variants of the human scavenger receptor class B type 1 and paraoxonase 1 on coronary heart disease: genotype-phenotype correlations. Arterioscler Thromb Vasc Biol 2005;25:854-860.
50. Morabia A, Ross BM, Costanza MC, Cayanis E, Flaherty MS, Alvin GB, Das K, James R, Yang AS, Evagrafov O, Gilliam TC. Population-based study of SR-BI genetic variation and lipid profile. Atherosclerosis 2004;175:159-168.
51. Rousset X, Vaisman B, Amar M, Sethi AA, Remaley AT. Lecithin: cholesterol acyl-transferase\from biochemistry to role in cardiovascular disease. Curr Opin Endo-crinol Diabetes Obes 2009;16:163-171.
52. Civeira F, Castillo S, Alonso R, Meriño-Ibarra E, Cenarro A, Artied M, Mart́in-Fuentes P, Ros E, Pocov́i, Mata P, for the Spanish Familial Hypercholester-olemia Group. Tendon xanthomas in familial hypercholesterolemia are associated with cardiovascular risk independent of the Low-density lipoprotein receptor gene mutation. Arterioscler Thromb Vasc Biol 2005;25:1960-1965.